From: Spoligotyping based genetic diversity of Mycobacterium tuberculosis in Ethiopia: a systematic review
Author | Study Regiona | Type of Patientsb | No. isolates | Typing methodc | No. strains | Clustering rate (%) | Shared rated (%) | Predominant strains | Lineage/Clade |
---|---|---|---|---|---|---|---|---|---|
Agonafir et al., 2010 [28] | AA | MDR-TB | 107 | Spoligotyping | 81 | 80.43 | 82.61 | SIT149 | T, CAS |
Deribew et al., 2012 [29] | OR | PTB | 17 | Spoligotyping | 17 | 64.71 | 64.71 | SIT777 | T, H, CAS |
Mihret et al., 2012 [30] | AA | PTB | 192 | Spoligotyping | 192 | 82.81 | 88.02 | SIT149 | T, CAS, H |
Ameni et al., 2013 [31] | OR | PTB | 139 | Spoligotyping | 130 | 71.54 | 84.62 | SIT149, SIT53 | EA, EAI |
Diriba et al., 2013 [32] | AA | MDR-TB | 184 | Spoligotyping | 184 | 85.87 | 77.72 | SIT21, SIT149 | EA and IO |
Firdessa et al., 2013 [17] | AA, AM, OR, SNNPR | PTB, ETB | 950 | Spoligotyping, MIRU-VNTR, SNP | 950 | 62.21 | 81.79 | SIT149, SIT25 | EA, EAI |
Garedew et al., 2013a [33] | AM | PTB | 71 | Spoligotyping | 96 | 85.42 | 94.79 | SIT149, SIT53 | EA |
Garedew et al., 2013b [34] | AM | ETB | 44 | Spoligotyping | 44 | 79.54 | 95.45 | SIT54, SIT53 | EA, IO |
Workalemahu et al., 2013 [36] | OR | Child TB | 15 | Spoligotyping | 24 | 54.17 | 54.17 | SIT37 | EA |
Yimer et al., 2013 [37] | AM | PTB | 237 | Spoligotyping and MIRU-VNTR | 237 | 83.54 | 82.70 | SIT25, SIT910 | CAS_DELHI |
Belay et al., 2014 [38] | AM | PTB | 105 | Spoligotyping | 103 | 77.67 | 93.20 | SIT149, SIT37 | T3-ETH, T3 |
Debebe et al., 2014 [39] | AM | PTB | 118 | Spoligotyping | 118 | 83.89 | 89.83 | SIT25 and SIT53 | EA, CAS |
Disassa et al., 2015 [42] | BG | PTB | 33 | Spoligotyping | 33 | 45.45 | 75.76 | SIT53 | EA |
Gebrezgabiher et al., 2015 [43] | SNNPR | PTB, ETB | 31 | Spoligotyping | 31 | 38.71 | 61.29 | SIT53 | EA |
Getahun et al., 2015 [44] | ETH | PTB | 92 | Spoligotyping | 91 | 70.33 | 58.24 | SIT53, SIT149 | EA, EAI |
Korma et al., 2015 [45] | AA | ETB | 58 | Spoligotyping | 58 | 60.34 | 82.76 | SIT53, SIT149 | T |
Maru et al., 2015 [46] | AM | PTB | 118 | Spoligotyping | 118 | 73.73 | 90.68 | SIT25, SIT53 | H, T, CAS-DELHI |
Nuru et al., 2015 [47] | AM | PTB, ETB | 168 | Spoligotyping | 168 | 58.33 | 72.62 | SIT289, SIT134 | EA, EAI |
Zewudie et al., 2016 [51] | AA | PTB, ETB | 73 | Spoligotyping | 73 | 61.64 | 79.45 | SIT149, SIT53 | T, CASI-DELHI |
Nuru et al., 2017 [52] | AM | PTB, ETB | 38 | Spoligotyping | 38 | 36.84 | 68.42 | SIT53, SIT289 | EA, EAI |
Bedawi et al., 2017 [54] | OR & SNNPR | PTB | 281 | Spoligotyping | 281 | 79.36 | 79.72 | SIT53, SIT149 | EA |